97 results on '"Grimm, Jimm"'
Search Results
52. Potential Clinical Significance of Overall Targeting Accuracy and Motion Management in the Treatment of Tumors That Move With Respiration: Lessons Learnt From a Quarter Century of Stereotactic Body Radiotherapy From Dose Response Models
53. Estimating the tolerance of Brachial Plexus to hypofractionated Stereotactic Body Radiotherapy – A modelling-based approach from clinical experience.
54. Targeting Accuracy Considerations for Simultaneous Tumor Treating Fields Antimitotic Therapy During Robotic Hypofractionated Radiation Therapy
55. Estimating the Tolerance of Brachial Plexus to Hypofractionated Stereotactic Body Radiotherapy – A Modelling-based Approach from Clinical Experience.
56. Dose-Volume Predictors of Radiation Pneumonitis After Lung Stereotactic Body Radiation Therapy (SBRT): Implications for Practice and Trial Design
57. A new view of performance analysis of transmit diversity schemes in correlated Rayleigh fading
58. Normal tissue complication probability of vertebral compression fracture after stereotactic body radiotherapy for de novo spine metastasis
59. A Dose-Response Model of Local Tumor Control Probability After Stereotactic Radiosurgery for Brain Metastases Resection Cavities
60. Tumor-Treating Field Arrays Do Not Reduce Target Volume Coverage for Glioblastoma Radiation Therapy
61. The 220 MHz ITS spectral allocation: potential, pitfalls, and applications
62. Updated risk models demonstrate low risk of symptomatic radionecrosis following stereotactic radiosurgery for brain metastases
63. RTHP-13. TUMOR-TREATING FIELDS THERAPY IS COMPATIBLE WITH STANDARD CHEMORADIOTHERAPY FOR GLIOBLASTOMA
64. Fitting NTCP models to SBRT dose and carotid blowout syndrome data
65. Abstract 676: Preliminary investigation into the dosimetric impact of tumor treating field arrays on concurrent radiotherapy for newly-diagnosed glioblastoma
66. RTHP-20. RADIATION THERAPY TARGETING ACCURACY WHEN COMBINED WITH ALTERNATING ELECTRIC FIELD THERAPY
67. Estimated Risk Level of Unified SBRT Dose Tolerance Limits for Spinal Cord
68. Small field dose measurements using plastic scintillation detector in heterogeneous media
69. Updated risk models demonstrate low risk of symptomatic radionecrosis following stereotactic radiosurgery for brain metastases.
70. Inverse treatment planning for spinal robotic radiosurgery: an international multi‐institutional benchmark trial
71. Introduction and Clinical Overview of the DVH Risk Map
72. Dose-Response Model for Chest Wall Tolerance of Stereotactic Body Radiation Therapy
73. Multisession Radiosurgery for Hearing Preservation
74. Esophageal Dose Tolerance in Patients Treated With Stereotactic Body Radiation Therapy
75. Factors that may determine the targeting accuracy of image‐guided radiosurgery
76. WE-F-304-00: Outcomes of Hypofractionated Treatments - Results of the WGSBRT
77. Biological implications of whole-brain radiotherapy versus stereotactic radiosurgery of multiple brain metastases
78. Dose-volume effects on brainstem dose tolerance in radiosurgery
79. Dosimetric investigation of accelerated partial breast irradiation (APBI) using CyberKnife
80. Evaluating Published Skin Dose Tolerance Limits for Stereotactic Body Radiation Therapy of Lung Cancer
81. Dose tolerance limits and dose volume histogram evaluation for stereotactic body radiotherapy
82. A quality assurance method with submillimeter accuracy for stereotactic linear accelerators
83. Anatomy-Based Inverse Planning Simulated Annealing Optimization in High-Dose-Rate Prostate Brachytherapy: Significant Dosimetric Advantage Over Other Optimization Techniques
84. Overview of dosimetric and biological perspectives on radiosurgery of multiple brain metastases in comparison with whole brain radiotherapy.
85. Biological implications of whole-brain radiotherapy versus stereotactic radiosurgery of multiple brain metastases.
86. Editorial.
87. High Efficiency Narrowband Wireless Modems for ITS Applications
88. Complication probability for radiation pneumonitis (RP) after stereotactic body radiotherapy (SBRT).
89. Dose-volume effects on brainstem dose tolerance in radiosurgery.
90. Dose Tolerance for Stereotactic Body Radiation Therapy.
91. (P041) Small Bowel Dose Tolerance in Stereotactic Body Radiation Therapy (SBRT) With Tumor Growth Inhibitors.
92. (P045) Esophagus Dose Tolerance for Stereotactic Body Radiation Therapy (SBRT).
93. MARKETING: A CONTEMPORARY INTRODUCTION.
94. Quantifying Rigid and Nonrigid Motion of Liver Tumors During Stereotactic Body Radiation Therapy.
95. In Reply to Klement et al.
96. Tumor-Treating Field Arrays Do Not Reduce Target Volume Coverage for Glioblastoma Radiation Therapy.
97. Overview of dosimetric and biological perspectives on radiosurgery of multiple brain metastases in comparison with whole brain radiotherapy.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.